EUVIMEDDescobrir EUVIMED
Open access · CC BY 4.0

Does Left Atrial Size and E/e′ Predict Outcomes in Hypertrophic Cardiomyopathy?

Brandon Tillson iD, Stephen Lord, Christopher Eggett

Echocardiography · 2025

DOI: 10.1111/echo.70345 ↗

At a glance

Journal article in Echocardiography, 2025. Written by Brandon Tillson and 2 co-authors. Institution: Faculty of Medical Sciences, Framlington Place, Newcastle University, England, UK. Major MEDLINE topics: Cardiomyopathy, Hypertrophic, Heart Atria, Echocardiography, Atrial Fibrillation. 31 references. The full text is freely available (open access, CC BY 4.0).

ResumoSubjectsDados bibliográficosCiteRelated studies

Abstract (original language)

Background

Atrial arrhythmia is prevalent in patients with hypertrophic cardiomyopathy (HCM) and is prognostically deleterious. Catheter ablation (CA) has poor efficacy in HCM, making predictors of outcome valuable. Left atrial size is associated with morbidity and mortality, and E/e′ has been proposed. The current study evaluates whether these predict non‐paroxysmal atrial arrhythmia, interventions for atrial arrhythmia and all‐cause mortality.

Methods

233 patients from the echocardiography database were included; patients with any mitral annular calcification were excluded. Medical records were reviewed for sample characteristics. Survival analysis was performed for left atrial diameter (LAD), left atrial volume index (LAVi, by area‐length method), and E/e′ with respect to endpoints, namely: non‐paroxysmal atrial arrhythmia; atrial intervention (composite of CA and pace‐and‐ablate); and all‐cause mortality. If LAD or LAVi were significant in multivariate analysis, ROC analysis and DeLong's test were performed to evaluate and compare their discriminative power.

Results

Over a median follow‐up of 8 years (median age 53, 73% male), the overall prevalence of non‐paroxysmal atrial arrhythmia was 31%. In multivariate models, LAVi was predictive of non‐paroxysmal atrial arrhythmia and atrial intervention; LAD was only predictive of arrhythmia. LAVi demonstrated greater discriminative power for predicting atrial intervention. E/e′ was not predictive of any outcome. No echocardiographic variable predicted death in multivariate analysis.

Conclusion

LAVi may have greater clinical utility compared to two‐dimensional measurements like LAD. Future work should clarify which measures of left atrial size are most appropriate in clinical practice.

Subjects

MeSH terms (MEDLINE)

Cardiomyopathy, HypertrophicHeart AtriaEchocardiographyAtrial FibrillationHumansMaleFemaleMiddle AgedOrgan SizePrognosisRetrospective StudiesSurvival RatePrevalenceReproducibility of Results

Author keywords

atrial fibrillationatrial fluttercardiomyopathycatheter ablationechocardiographyhypertrophicleft atrium

Authors and institutions

  • Faculty of Medical Sciences, Framlington Place, Newcastle University, England, UK.
  • Freeman Hospital, England, UK.

ORCID profiles: Brandon Tillson

Cite

APA

Tillson, B., Lord, S., & Eggett, C. (2025). Does Left Atrial Size and E/e′ Predict Outcomes in Hypertrophic Cardiomyopathy?. Echocardiography. https://doi.org/10.1111/echo.70345

Vancouver

Tillson B, Lord S, Eggett C. Does Left Atrial Size and E/e′ Predict Outcomes in Hypertrophic Cardiomyopathy?. Echocardiography. 2025. doi:10.1111/echo.70345

BibTeX
@article{Tillson2025,
  author = {Tillson, Brandon and Lord, Stephen and Eggett, Christopher},
  title = {Does Left Atrial Size and E/e′ Predict Outcomes in Hypertrophic Cardiomyopathy?},
  journal = {Echocardiography},
  year = {2025},
  doi = {10.1111/echo.70345}
}
Start for free →